000 04823nam a22006255i 4500
001 978-3-031-65808-2
003 DE-He213
005 20251030112931.0
007 cr nn 008mamaa
008 240719s2024 sz | s |||| 0|eng d
020 _a9783031658082
_9978-3-031-65808-2
024 7 _a10.1007/978-3-031-65808-2
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
072 7 _aMJCL
_2thema
245 1 0 _aBreast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach
_h[electronic resource] /
_cedited by Nima Rezaei.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aXI, 435 p. 24 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aInterdisciplinary Cancer Research,
_x2731-457X ;
_v6
505 0 _aRole of miRNAs in Triple-Negative Breast Cancer: Diagnosis, Prognosis, and Treatment -- Approaches to Breast Cancer Immunology and Immunotherapy -- Molecular Genetics of Breast Cancer: From Mechanistic Insights to the Therapeutic Approaches -- Interleukins in the Development and Progression of Breast Cancer -- Shaping of the Immune Landscape by Chemokine Receptors that Impacts the Clinical Outcome in Triple-Negative Breast Cancer -- The Prognostic Impact of Tumor-Infiltrated Lymphocytes (TILs) in Breast Cancer -- From Genes to Recovery: Precision Medicine and Its Influence on Multidrug Resistant Breast Cancer -- Recent Progress and Prospects of Immunotherapy in Multidrug-Resistant and Metastatic Breast Cancer Treatment -- Targeting Myeloid Determinants of Breast Cancer -- siRNA Loaded in Drug Delivery Nanosystems as a Strategy for Breast Cancer Treatment -- Nucleic Acid and Drug Dual Agent Nanoplatforms for Breast Cancer -- Oncolytic Virotherapy Against Breast Cancer -- Overcoming Breast Cancer Resistance to Targeted, Chemo-, and Immuno Therapy: Mechanisms and Strategies to Overcome Resistance and Facilitate Drug Development.
520 _aGenetics have a role in the presence of breast cancer, while the potential role of the immune system leads to consideration of immunotherapy in the treatment of the disease, particularly in metastatic triple-negative breast cancer. The sixth volume of the “Interdisciplinary Cancer Research” series, entitled “Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach” publishes comprehensive volumes on immune and genetic mechanisms of breast cancer diagnosis and prognosis. The role of molecular genetics, interleukins, chemokine receptor, and tumor-infiltrated lymphocytes-TILS in breast cancer are explained. Targeting myeloid determinants, SiRNA loaded in drug delivery nanosystems, nucleic acid and drug dual agent nanoplatforms, and oncolytic virotherapy are also discussed in the treatment of breast cancer, particularly in multidrug resistant and metastatic breast cancer. This interdisciplinary series is of special value to researchers working on immunology, genetics, and practitioners working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value to researchers, oncologists, geneticists, and immunologists who wish to extend their knowledge on breast cancer.
650 0 _aCancer.
_94311
650 0 _aCancer
_xTreatment.
_963722
650 0 _aCancer
_xGenetic aspects.
_973501
650 0 _aOncology.
_970760
650 0 _aTumors
_xImmunological aspects.
_973413
650 0 _aImmunotherapy.
_969215
650 1 4 _aCancer Biology.
_967829
650 2 4 _aCancer Therapy.
_973414
650 2 4 _aCancer Genetics and Genomics.
_973502
650 2 4 _aOncology.
_970760
650 2 4 _aTumour Immunology.
_973415
650 2 4 _aImmunotherapy.
_969215
700 1 _aRezaei, Nima.
_eeditor.
_0(orcid)0000-0002-3836-1827
_1https://orcid.org/0000-0002-3836-1827
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_977538
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031658075
776 0 8 _iPrinted edition:
_z9783031658099
776 0 8 _iPrinted edition:
_z9783031658105
830 0 _aInterdisciplinary Cancer Research,
_x2731-457X ;
_v6
856 4 0 _uhttps://doi.org/10.1007/978-3-031-65808-2
912 _aZDB-2-SBL
912 _aZDB-2-SXB
999 _c63023
_d63023